weight loss, Food and Drug Administration
Super Bowl ad for Hims & Hers' weight loss drug sparks backlash
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, which both contain the active ingredient semaglutide and are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes and obesity, respectively.
The complicated world of compounded weight-loss drugs
On Super Bowl Sunday, many tuning into the big game saw a controversial ad from the telehealth company Hims & Hers. The minute-long spot begins by skewering the American health care system, saying it's "designed to keep us sick and stuck" while profiting off of America's obesity epidemic.
This discussion will explore the most effective weight loss supplement for women over 50. When it comes to weight ... Pills for those looking for an FDA-approved weight loss supplement ...
The manufacturers claim that the ingredients in these patches help people lose weight. People apply the patches to their skin over the ... aid weight loss. The FDA has not approved ...
Zyn nicotine pouches loved by young people for their appetite-suppressing effects have officially been approved in the US. The FDA said it found ... helping them lose weight, likening them to ...
Her doctor prescribed the cheaper, generic version of the weight-loss drug after her insurer ... the only version available will be the FDA-approved, pricier type. She feels like the rug has ...
Similarly, pharmaceutical manufacturers of FDA-approved weight loss therapeutics have pushed back against compounding pharmacies, saying the products they make can be unsafe. What’s driving this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback